Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients.

Gianni M, Bosch J, Pogue J, Probstfield J, Dagenais G, Yusuf S, Lonn E.

Eur Heart J. 2007 Jun;28(11):1382-8. Epub 2007 Mar 29.

PMID:
17395677
2.

Effect of long-term therapy with ramipril in high-risk women.

Lonn E, Roccaforte R, Yi Q, Dagenais G, Sleight P, Bosch J, Suhan P, Micks M, Probstfield J, Bernstein V, Yusuf S; HOPE Investigators. Heart Outcomes Prevention Evaluation..

J Am Coll Cardiol. 2002 Aug 21;40(4):693-702.

3.

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G.

N Engl J Med. 2000 Jan 20;342(3):145-53. Erratum in: 2000 May 4;342(18):1376. N Engl J Med 2000 Mar 9;342(10):748.

4.

The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.

Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Mann JF, Dagenais G, Lonn E; HOPE Investigators..

J Cardiovasc Electrophysiol. 2009 Jul;20(7):781-7. doi: 10.1111/j.1540-8167.2009.01440.x. Epub 2009 Feb 27.

PMID:
19298567
5.

The HOPE Study (Heart Outcomes Prevention Evaluation).

Sleight P.

J Renin Angiotensin Aldosterone Syst. 2000 Mar;1(1):18-20. Review.

PMID:
11967789
6.

Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.

Teo KK, Mitchell LB, Pogue J, Bosch J, Dagenais G, Yusuf S; HOPE Investigators..

Circulation. 2004 Sep 14;110(11):1413-7. Epub 2004 Sep 7.

7.

Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study.

Arnold JM, Yusuf S, Young J, Mathew J, Johnstone D, Avezum A, Lonn E, Pogue J, Bosch J; HOPE Investigators..

Circulation. 2003 Mar 11;107(9):1284-90.

8.

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S.

Ann Intern Med. 2001 Apr 17;134(8):629-36.

PMID:
11304102
9.

Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.

Bosch J, Lonn E, Pogue J, Arnold JM, Dagenais GR, Yusuf S; HOPE/HOPE-TOO Study Investigators..

Circulation. 2005 Aug 30;112(9):1339-46.

10.

Diabetes and the HOPE study: implications for macrovascular and microvascular disease.

Gerstein HC.

Int J Clin Pract Suppl. 2001 Jan;(117):8-12.

PMID:
11715357
11.

[The HOPE Study. What does it contribute to general practice?].

Mann J, Sleight P.

MMW Fortschr Med. 2000 Nov 23;142(47):28-32. German.

PMID:
11143776
12.
13.

The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not.

Hoogwerf BJ, Young JB.

Cleve Clin J Med. 2000 Apr;67(4):287-93.

PMID:
10780101
15.

Ramipril: a review of its use in preventing cardiovascular outcomes in high-risk patients.

Anderson VR, Perry CM, Robinson DM.

Am J Cardiovasc Drugs. 2006;6(6):417-32. Review.

PMID:
17192135
16.

Ramipril: a review of its use in the prevention of cardiovascular outcomes.

Warner GT, Perry CM.

Drugs. 2002;62(9):1381-405. Review.

PMID:
12076194
17.

Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study.

Dagenais GR, Yusuf S, Bourassa MG, Yi Q, Bosch J, Lonn EM, Kouz S, Grover J; HOPE Investigators..

Circulation. 2001 Jul 31;104(5):522-6.

18.

Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study.

Mann JF, Yi QL, Sleight P, Dagenais GR, Gerstein HC, Lonn EM, Bosch J; HOPE Investigators..

Clin Nephrol. 2005 Mar;63(3):181-7.

PMID:
15786818
19.

Spotlight on ramipril in the prevention of cardiovascular outcomes.

Warner GT, Perry CM.

Am J Cardiovasc Drugs. 2003;3(2):113-6. Review.

PMID:
14727938
20.

Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?

Boos CJ.

Med Sci Monit. 2004 Dec;10(12):SR23-8.

PMID:
15567997

Supplemental Content

Support Center